CONCORD BIOTECH LIMITED INDIA

Company Type: Manufacturer (Factory)

Company Introduction:

Concord Biotech Limited India is a prominent biopharmaceutical company based in India, primarily engaged in the research, development, manufacturing, and marketing of fermentation-based Active Pharmaceutical Ingredients (APIs) and formulations. It is recognized as one of the largest developers and manufacturers of specific fermentation-based APIs globally.

The company's product portfolio spans various therapeutic areas, including immunosuppressants, oncology drugs, and anti-fungal drugs. Concord Biotech operates state-of-the-art manufacturing facilities adhering to international quality standards and places a strong emphasis on research and development to innovate and produce high-quality pharmaceutical products. Its products are supplied to diverse markets across the globe, establishing it as a significant and reliable player in the global biopharmaceutical industry.

Products:

1. Active Pharmaceutical Ingredients (APIs)

- Immunosuppressants: Tacrolimus, Mycophenolate Mofetil, Sirolimus, Cyclosporine

- Anti-infectives: Daptomycin, Caspofungin, Micafungin, Ertapenem, Meropenem, Voriconazole, Posaconazole, Anidulafungin

- Other APIs: Ursodeoxycholic Acid

2. Finished Formulations (Drug Products)

- Immunosuppressants: Tablets, capsules, and oral solutions containing Tacrolimus, Mycophenolate Mofetil, Sirolimus, and Cyclosporine

- Anti-infectives: Injectable formulations containing Daptomycin, Caspofungin, and Micafungin

- Products for various therapeutic areas including Nephrology, Oncology, Ophthalmology, and Critical Care, primarily derived from their portfolio of fermentation-based APIs.